Consistently with this, a recent study using mass spectrometry (MS)-based proteomics analysis in tumor and adjacent non-tumor tissues from 159 patients with HCC has also revealed the down-regulation of SLC25A20 and its correlation with poor survival of patients with HCC10. This evidence concerns the gene SLC25A20 and hepatocellular carcinoma.